This poster demonstrates the predictive validity of an assay developed by Arbor Vita and PATH. For this study, cervical swab specimens collected from women screened, diagnosed, and managed in rural settings in China were tested for the presence of HPV-16 DNA then examined for HPV16-E6 expression. Results confirmed E6 is a potential diagnostic marker. Presented at: 23rd Papillomavirus Conference and Clinical Workshop, September 1, 2006; Prague, Czech Republic.
Author(s): Schweizer J, Somoza C, Mahoney C, et al
Corporate author(s): PATH, Arbor Vita Corporation, Chinese Academy of Medical Sciences
Publication date: September 2006
76 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- Health technologies > Diagnostic technologies
- Reproductive health > Cervical cancer prevention
- Reproductive health > Sexually transmitted infections
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA